Duhamel, H. L. Sur une racine qui a la faculte de triendre en rouge les os des animaux vivants. Mem. Acad. R. Sci. Paris 52, 1–13 (1739).
Rana, R. S., Wu, J. S. & Eisenberg, R. L. Periosteal reaction. Am. J. Roentgenol. 193, W259–W272 (2009).
Vilchez Mercedes, S. A. et al. Decoding leader cells in collective cancer invasion. Nat. Rev. Cancer 21, 592–604 (2021).
Friedl, P. & Wolf, K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 3, 362–374 (2003).
Baracos, V. E., Martin, L., Korc, M., Guttridge, D. C. & Fearon, K. C. H. Cancer-associated cachexia. Nat. Rev. Dis. Primers 4, 17105 (2018).
Winer, A., Adams, S. & Mignatti, P. Matrix metalloproteinase inhibitors in cancer therapy: turning past failures into future successes. Mol. Cancer Ther. 17, 1147–1155 (2018).
Jackson, H. W., Defamie, V., Waterhouse, P. & Khokha, R. TIMPs: versatile extracellular regulators in cancer. Nat. Rev. Cancer 17, 38–53 (2017).
Hermann, C. D. et al. TIMP1 expression underlies sex disparity in liver metastasis and survival in pancreatic cancer. J. Exp. Med. 218, e20210911 (2021).
Shimoda, M. et al. Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state. Nat. Cell Biol. 16, 889–901 (2014).
Grünwald, B. et al. Pancreatic premalignant lesions secrete tissue inhibitor of metalloproteinases-1, which activates hepatic stellate cells via CD63 signaling to create a premetastatic niche in the liver. Gastroenterology 151, 1011–1024.e1017 (2016).
Osawa, Y. et al. Liver acid sphingomyelinase inhibits growth of metastatic colon cancer. J. Clin. Invest. 123, 834–843 (2013).
Head and neck squamous cell carcinoma. Nat. Rev. Dis. Primers 6, 93 (2020).
Tsukasaki, M. et al. Periosteal stem cells control growth plate stem cells during postnatal skeletal growth. Nat. Commun. 13, 4166 (2022).
Park, J. et al. CCL28-induced RARβ expression inhibits oral squamous cell carcinoma bone invasion. J. Clin. Invest. 129, 5381–5399 (2019).
Takaoka, M. et al. Ha-RasG12V induces senescence in primary and immortalized human esophageal keratinocytes with p53 dysfunction. Oncogene 23, 6760–6768 (2004).
Nakagawa, H. et al. The targeting of the cyclin D1 oncogene by an Epstein–Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach. Oncogene 14, 1185–1190 (1997).
Sun, X. et al. Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy. Nat. Nanotechnol. 16, 1260–1270 (2021).
Hashimoto, K., Sato, S., Ochi, H., Takeda, S. & Futakuchi, M. Calvarial bone implantation and. Bio Protoc. 9, e3151 (2019).
Hashimoto, K. et al. Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A. Proc. Natl Acad. Sci. USA 115, 2204–2209 (2018).
Network, C. G. A. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517, 576–582 (2015).
Alshetaiwi, H. et al. Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics. Sci. Immunol. 5, eaay6017 (2020).
Tsukasaki, M. & Takayanagi, H. Osteoimmunology: evolving concepts in bone-immune interactions in health and disease. Nat. Rev. Immunol. 19, 626–642 (2019).
Debnath, S. et al. Discovery of a periosteal stem cell mediating intramembranous bone formation. Nature 562, 133–139 (2018).
Wilson, W. R. & Hay, M. P. Targeting hypoxia in cancer therapy. Nat. Rev. Cancer 11, 393–410 (2011).
Otani, S. et al. Runx3 is required for oncogenic Myc upregulation in p53-deficient osteosarcoma. Oncogene 41, 683–691 (2022).
Julien, A. et al. Skeletal stem/progenitor cells in periosteum and skeletal muscle share a common molecular response to bone injury. J. Bone Miner. Res. 37, 1545–1561 (2022).
Eckfeld, C. et al. TIMP-1 is a novel ligand of amyloid precursor protein and triggers a proinflammatory phenotype in human monocytes. J. Cell Biol. 222, e202206095 (2023).
Hirasawa, T. & Kuratani, S. Evolution of the vertebrate skeleton: morphology, embryology, and development. Zoological Lett. 1, 2 (2015).
Shimada, A. et al. Trunk exoskeleton in teleosts is mesodermal in origin. Nat. Commun. 4, 1639 (2013).
Kajita, M. et al. Filamin acts as a key regulator in epithelial defence against transformed cells. Nat. Commun. 5, 4428 (2014).
Morata, G. & Ripoll, P. Minutes: mutants of Drosophila autonomously affecting cell division rate. Dev. Biol. 42, 211–221 (1975).
de la Cova, C., Abril, M., Bellosta, P., Gallant, P. & Johnston, L. A. Drosophila myc regulates organ size by inducing cell competition. Cell 117, 107–116 (2004).
Hogan, C. et al. Characterization of the interface between normal and transformed epithelial cells. Nat. Cell Biol. 11, 460–467 (2009).
Nakamura, T. et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130, 811–823 (2007).
Wang, H. et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153, 910–918 (2013).
Tsukasaki, M. et al. Stepwise cell fate decision pathways during osteoclastogenesis at single-cell resolution. Nat. Metab. 2, 1382–1390 (2020).
Asano, T. et al. Soluble RANKL is physiologically dispensable but accelerates tumour metastasis to bone. Nat. Metab. 1, 868–875 (2019).
Tsukasaki, M. et al. Host defense against oral microbiota by bone-damaging T cells. Nat. Commun. 9, 701 (2018).
Tsukasaki, M. et al. OPG production matters where it happened. Cell Rep. 32, 108124 (2020).
Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90–W97 (2016).
Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013).
Xie, Z. et al. Gene Set Knowledge Discovery with Enrichr. Curr. Protoc. 1, e90 (2021).
The Galaxy Community The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update. Nucleic Acids Res. 50, W345–W351 (2022).
Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24–26 (2011).
Yan, M. et al. ETS1 governs pathological tissue-remodeling programs in disease-associated fibroblasts. Nat. Immunol. 23, 1330–1341 (2022).
Akimoto, M., Maruyama, R., Takamaru, H., Ochiya, T. & Takenaga, K. Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment. Nat. Commun. 7, 13589 (2016).
Kazu. nakamurakazu/Stromal-defence-against-cancer-by-the-periosteum: stromal defence against cancer by the periosteum. Zenodo https://doi.org/10.5281/zenodo.12204268 (2024).